<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty-three patients with the 'primary' <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> were studied over 2-6 years </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-two (96%) had <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> detected by ELISA (87% had antibodies to thromboplastin and 70% to <z:chebi fb="0" ids="28494">cardiolipin</z:chebi>), and 18 out of the 21 tested patients (86%) had <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity by coagulative assays </plain></SENT>
<SENT sid="2" pm="."><plain>Mean age of the cohort was 29.9 years and the sex ratio (female:male) 4.75:1 </plain></SENT>
<SENT sid="3" pm="."><plain>Eleven patients presented 18 venous and/or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> and 13 had 25 foetal losses (84% occurred during the second and third trimester) </plain></SENT>
<SENT sid="4" pm="."><plain>Other clinical features were <z:hpo ids='HP_0002076'>migraine</z:hpo>, <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo>, and <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Three patients had relatives with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0040034" disease_type="Disease or Syndrome" abbrv="">Thrombocytopaenia</z:e> was seen in 33%, <z:hpo ids='HP_0003493'>antinuclear antibodies</z:hpo> in low or moderate titre in 30%, and <z:hpo ids='HP_0001878'>haemolytic anaemia</z:hpo> in 13% </plain></SENT>
<SENT sid="7" pm="."><plain>During the follow-up, two patients presented <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo> despite <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy, one of them dying because of recurrent pulmonary <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Four patients achieved successful term pregnancies after treatment with aspirin and a further patient after treatment with aspirin and low dose <z:chebi fb="2" ids="8378">prednisolone</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>No patient developed <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> or any other definable <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disease</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The 'primary' <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> may exist as a distinct clinical entity and <z:hpo ids='HP_0000001'>all</z:hpo> younger patients presenting with thrombotic events, foetal losses and/or <z:e sem="disease" ids="C0040034" disease_type="Disease or Syndrome" abbrv="">thrombocytopaenia</z:e>, without any evidence of a well defined disease, should be tested for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in order to rule out this syndrome </plain></SENT>
</text></document>